Takeshi Shiraishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takeshi Shiraishi has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Takayuki Shirakusa
13 shared publications- Akinori Iwasaki
Department of Thoracic Surgery, School of Medicine, Fukuoka University, Fukuoka, Japan
11 shared publications Akinori Iwasaki
Department of General Thoracic, Breast and Pediatric Surgery, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan
9 shared publicationsMasafumi Hiratsuka
Department of General Thoracic, Breast and Pediatric Surgery, Fukuoka University School of Medicine, Fukuoka City, Fukuoka, Japan
8 shared publicationsSatoshi Yamamoto
6 shared publicationsSo Miyahara
Center of Organ Transplant Medicine (Lung Transplant Unit), Fukuoka University Hospital, Fukuoka, Japan
6 shared publications
Latest Publications
- Open Access
- 1 September 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (9) , 5204-5212
The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success
Japan is a unique country in terms of organ transplantation. Despite the impressive progress in transplant medicine achieved during the late 20th century in many Western countries, Japan was unable to implement a program for organ transplants from brain-dead donors due to persistent public distrust regarding the ethical understanding of “brain death as human death”. In 1997, the Japanese Organ Transplant Law was enacted, and organ transplantation from brain-dead donors was finally legalized. However, this law was strongly opposed by religious leaders, philosophers, politicians, and even medical personnel who did not accept the idea that brain death is human death, so transplant physicians had to start performing transplants in the face of strong social resistance. The Japanese National Lung Transplant System was established based on the following three philosophies: (I) an institutional certification system based on strict standards; (II) a rigorous central monitoring system for transplant results; and (III) a third-party review system to determine eligibility for patient registration. The purpose of these policies was to avoid ethical issues at lung transplant institutes, and to achieve high-quality transplant results. The actual progress of Japanese lung transplantation has been quite unusual compared to other countries. The number of brain-dead organ donations was extremely limited at first, so more than 60% of lung transplants were performed as living-donor transplants during the first 9 years [1998–2006]. The number of brain-dead donations subsequently increased, particularly after the revision of the Organ Transplant Law in 2010 such that the majority of lung transplants are now performed as brain-dead transplantations. Regarding the results of lung transplants, the most recent national registry report indicated that a total of 668 lung transplants including 447 from brain-dead donors and 221 from living donors, had been performed as of 2018. The 5- and 10-year survival rates for brain-dead donor lung transplantation were 71.9% and 57.8%, respectively, with no significant difference between the living-donor and brain-dead-donor groups. These results are comparable with the outcome of preceding programs in the US and European countries.
- 1 September 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (9) , 5204-5212
Open AccessThe history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success
Japan is a unique country in terms of organ transplantation. Despite the impressive progress in transplant medicine achieved during the late 20th century in many Western countries, Japan was unable to implement a program for organ transplants from brain-dead donors due to persistent public distrust regarding the ethical understanding of “brain death as human death”. In 1997, the Japanese Organ Transplant Law was enacted, and organ transplantation from brain-dead donors was finally legalized. However, this law was strongly opposed by religious leaders, philosophers, politicians, and even medical personnel who did not accept the idea that brain death is human death, so transplant physicians had to start performing transplants in the face of strong social resistance. The Japanese National Lung Transplant System was established based on the following three philosophies: (I) an institutional certification system based on strict standards; (II) a rigorous central monitoring system for transplant results; and (III) a third-party review system to determine eligibility for patient registration. The purpose of these policies was to avoid ethical issues at lung transplant institutes, and to achieve high-quality transplant results. The actual progress of Japanese lung transplantation has been quite unusual compared to other countries. The number of brain-dead organ donations was extremely limited at first, so more than 60% of lung transplants were performed as living-donor transplants during the first 9 years [1998–2006]. The number of brain-dead donations subsequently increased, particularly after the revision of the Organ Transplant Law in 2010 such that the majority of lung transplants are now performed as brain-dead transplantations. Regarding the results of lung transplants, the most recent national registry report indicated that a total of 668 lung transplants including 447 from brain-dead donors and 221 from living donors, had been performed as of 2018. The 5- and 10-year survival rates for brain-dead donor lung transplantation were 71.9% and 57.8%, respectively, with no significant difference between the living-donor and brain-dead-donor groups. These results are comparable with the outcome of preceding programs in the US and European countries.
- 1 July 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 59 (4) , 428-435
Elucidation of prognostic factors and the effect of anti-fibrotic therapy on waitlist mortality in lung transplant candidates with idiopathic interstitial pneumonias
- 1 July 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 59 (4) , 428-435
Elucidation of prognostic factors and the effect of anti-fibrotic therapy on waitlist mortality in lung transplant candidates with idiopathic interstitial pneumonias
- 15 September 2020
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 69 (2) , 375-378
Severe scoliosis with an impaired pulmonary allograft function after pediatric unilateral lung transplantation
Left‐unilateral single‐lobe lung transplantation from a living donor was performed in a 4-year-old boy who suffered from severe respiratory failure caused by bronchiolitis obliterans (BO) as a result of graft versus host disease (GVHD) after peripheral blood stem cell transplantation (PBSCT). The patient grew well during his early childhood years, with an excellent lung allograft function. However, severe thoracic scoliosis occurred 7 years after lung transplantation, which ultimately resulted in compression of the lung allograft followed by severe respiratory dysfunction, and the patient became dependent on mechanical ventilation support. Posterior spinal fusion of Th2‐L3 with instrumentation and bone grafting was performed to correct scoliosis in the hope of recovering his thoracic capacity. The left thoracic volume was dramatically improved immediately after spinal fusion surgery, and the patient was ultimately weaned off of mechanical ventilation after a year of pulmonary rehabilitation.
- 15 September 2020
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 69 (2) , 375-378
Severe scoliosis with an impaired pulmonary allograft function after pediatric unilateral lung transplantation
Left‐unilateral single‐lobe lung transplantation from a living donor was performed in a 4-year-old boy who suffered from severe respiratory failure caused by bronchiolitis obliterans (BO) as a result of graft versus host disease (GVHD) after peripheral blood stem cell transplantation (PBSCT). The patient grew well during his early childhood years, with an excellent lung allograft function. However, severe thoracic scoliosis occurred 7 years after lung transplantation, which ultimately resulted in compression of the lung allograft followed by severe respiratory dysfunction, and the patient became dependent on mechanical ventilation support. Posterior spinal fusion of Th2‐L3 with instrumentation and bone grafting was performed to correct scoliosis in the hope of recovering his thoracic capacity. The left thoracic volume was dramatically improved immediately after spinal fusion surgery, and the patient was ultimately weaned off of mechanical ventilation after a year of pulmonary rehabilitation.
- 17 September 2019
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 68 (4) , 411-413
Pulmonary artery “conduit” reconstruction using bovine pericardium following long-segment sleeve resection: a unique “in situ tailor-made” sewing method
We describe a unique technique for pulmonary artery reconstruction using a bovine pericardial conduit after long-segment sleeve resection of the pulmonary artery. In this technique, the conduit tube was not created in advance but was sewn in situ from a bovine pericardial “sheet” step-by-step to form a desirable diameter, length and curve to fit the vascular defect. This is a safe and secure method to create desirable conduit for long and complex pulmonary artery replacement.
- 17 September 2019
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 68 (4) , 411-413
Pulmonary artery “conduit” reconstruction using bovine pericardium following long-segment sleeve resection: a unique “in situ tailor-made” sewing method
We describe a unique technique for pulmonary artery reconstruction using a bovine pericardial conduit after long-segment sleeve resection of the pulmonary artery. In this technique, the conduit tube was not created in advance but was sewn in situ from a bovine pericardial “sheet” step-by-step to form a desirable diameter, length and curve to fit the vascular defect. This is a safe and secure method to create desirable conduit for long and complex pulmonary artery replacement.
- 30 August 2019
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 68 (9) , 1043-1046
Transposition of pulmonary veins for mobilization of residual right middle and lower lobes after carinal right upper lobectomy: a unique pulmonary hilar mobilization technique for safe tension-free airway anastomosis
Unique right hilar mobilization was performed by pulmonary venous transposition of the right middle and lower lobe veins to the opening of the right upper pulmonary vein to achieve tension-free airway anastomosis after carinal right upper lobectomy for a patient with adenoid cystic carcinoma. The right middle and lower lobes were reconstructed safely thereafter by side-to-end anastomosis between the side of the lower trachea and intermediate bronchus with acceptable suturing tension.
- 30 August 2019
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 68 (9) , 1043-1046
Transposition of pulmonary veins for mobilization of residual right middle and lower lobes after carinal right upper lobectomy: a unique pulmonary hilar mobilization technique for safe tension-free airway anastomosis
Unique right hilar mobilization was performed by pulmonary venous transposition of the right middle and lower lobe veins to the opening of the right upper pulmonary vein to achieve tension-free airway anastomosis after carinal right upper lobectomy for a patient with adenoid cystic carcinoma. The right middle and lower lobes were reconstructed safely thereafter by side-to-end anastomosis between the side of the lower trachea and intermediate bronchus with acceptable suturing tension.
- 15 July 2018
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 32 (5) , 635-640
Bronchial resection and reconstruction without lung parenchymal resection for endobronchial tumor
2014年の胸部外科学会学術調査報告によると気管・気管支形成術のうち肺切除を伴わない気管支のみの切除再建術はわずか13例(2.0%)である.当施設ではこの希少な術式を5例に経験した.組織型は定型カルチノイド3例,脂肪腫1例,扁平上皮癌1例.腫瘍の局在は右中間気管支幹2例,左主気管支2例,左下葉支1例.平均手術時間は335±104分,平均出血量は301±372 mlであった.1例に一時的な呼吸不全,別の1例に吻合部狭窄を認めたが,バルーン拡張で改善した.全例が正常に社会復帰し局所・遠隔再発は認めていない.術前後に呼吸機能を測定し得た3症例では,呼吸機能改善が確認できた.気管支原発の良性,あるいは低悪性度悪性腫瘤において,肺機能温存を目的とした肺切除を伴わない気管支切除・再建術は,手術による根治性が担保できる範囲で有用な機能温存術式と考えられる.
- 15 July 2018
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 32 (5) , 635-640
Bronchial resection and reconstruction without lung parenchymal resection for endobronchial tumor
2014年の胸部外科学会学術調査報告によると気管・気管支形成術のうち肺切除を伴わない気管支のみの切除再建術はわずか13例(2.0%)である.当施設ではこの希少な術式を5例に経験した.組織型は定型カルチノイド3例,脂肪腫1例,扁平上皮癌1例.腫瘍の局在は右中間気管支幹2例,左主気管支2例,左下葉支1例.平均手術時間は335±104分,平均出血量は301±372 mlであった.1例に一時的な呼吸不全,別の1例に吻合部狭窄を認めたが,バルーン拡張で改善した.全例が正常に社会復帰し局所・遠隔再発は認めていない.術前後に呼吸機能を測定し得た3症例では,呼吸機能改善が確認できた.気管支原発の良性,あるいは低悪性度悪性腫瘤において,肺機能温存を目的とした肺切除を伴わない気管支切除・再建術は,手術による根治性が担保できる範囲で有用な機能温存術式と考えられる.
- 1 October 2016
- Vol. 69 (11) , 900-905
[Prevention and Treatment Strategy for Infectious Complication after Lung Transplantation].
The most frequent cause of death within a year after lung transplantation is infectious complications, which shifts to chronic allograft rejection or chronic lung allograft dysfunction(CLAD) thereafter. It is no doubt that minimization of the dose of immunosuppression within the acceptable therapeutic range is a best strategy to avoid infectious complications however, adequate dose of immunosuppressant is mandatory to protect lung allografts from acute or chronic rejection. Carefully balanced therapy of immunosuppression and infection control is extremely important for patient's long term survival after lung transplantation. Total 344 transplants were performed in Japan until the end of 2013, and the 5-year post-operative survival was reported as more than 70% which is superior than North American or European registry data. However, more than 30% of death is still caused by infectious complications thus appropriate prevention and treatment for infection is important for better long term results. Here in this paper, the 1st 10-year experience of Fukuoka University Lung Transplant Program was reported and discussed especially focusing on infectious complications.
- 1 October 2016
- Vol. 69 (11) , 900-905
[Prevention and Treatment Strategy for Infectious Complication after Lung Transplantation].
The most frequent cause of death within a year after lung transplantation is infectious complications, which shifts to chronic allograft rejection or chronic lung allograft dysfunction(CLAD) thereafter. It is no doubt that minimization of the dose of immunosuppression within the acceptable therapeutic range is a best strategy to avoid infectious complications however, adequate dose of immunosuppressant is mandatory to protect lung allografts from acute or chronic rejection. Carefully balanced therapy of immunosuppression and infection control is extremely important for patient's long term survival after lung transplantation. Total 344 transplants were performed in Japan until the end of 2013, and the 5-year post-operative survival was reported as more than 70% which is superior than North American or European registry data. However, more than 30% of death is still caused by infectious complications thus appropriate prevention and treatment for infection is important for better long term results. Here in this paper, the 1st 10-year experience of Fukuoka University Lung Transplant Program was reported and discussed especially focusing on infectious complications.
- 1 January 2015
- Published by Japan Broncho-Esophagological Society in Nihon Kikan Shokudoka Gakkai Kaiho
- Vol. 66 (5) , 351-356
Airway Intervention Treatment for Infants
- 1 January 2015
- Published by Japan Broncho-Esophagological Society in Nihon Kikan Shokudoka Gakkai Kaiho
- Vol. 66 (5) , 351-356
Airway Intervention Treatment for Infants
- 1 January 2015
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 29 (7) , 863-868
A case of B6 bronchial flap reconstruction for patient with low-grade mucoepidermoid carcinoma
- 1 January 2015
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 29 (7) , 863-868
A case of B6 bronchial flap reconstruction for patient with low-grade mucoepidermoid carcinoma
- 1 May 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (5) , e47-e49
Successful lung volume reduction surgery in an infant with emphysema after respiratory syncytial virus-induced obliterative bronchiolitis
- 1 May 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (5) , e47-e49
Successful lung volume reduction surgery in an infant with emphysema after respiratory syncytial virus-induced obliterative bronchiolitis